Not Medicare Enrolled
Dr. Linli Xuan, MD
Medical Oncology · Olympia, WA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Xuan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Xuan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Xuan
Dr. Linli Xuan is a medical oncology specialist in Olympia, WA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Xuan performed 100,687 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Xuan received a total of $15,339 from 88 pharmaceutical and/or device companies across 573 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Xuan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 4% volume in WA
$15,339 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗100,687
Medicare services
Top 4% in WA for medical oncology
Not available
Unique patients (not deduplicated)
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
36,720 | $0 | $4 |
| Denosumab injection (Prolia/Xgeva) | 24,600 | $18 | $64 |
| Filgrastim injection, 1 microgram An injection of filgrastim, a medication that stimulates the production of white blood cells. This code specifically covers the brand-name drug and excludes biosimilar versions. |
9,720 | $1 | $3 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
5,741 | $6 | $25 |
| Anti-nausea injection (aprepitant) | 3,900 | $1 | $6 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
3,630 | $26 | $114 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,768 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,036 | $8 | $9 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,982 | $8 | $29 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,707 | $94 | $390 |
| Anti-nausea injection (ondansetron/Zofran) | 1,448 | $0 | $3 |
| Anti-nausea injection (Aloxi/palonosetron) | 840 | $1 | $41 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
549 | $11 | $67 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
494 | $12 | $66 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
461 | $102 | $421 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
297 | $22 | $103 |
| Injection, potassium chloride, per 2 meq | 285 | $0 | $4 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
269 | $139 | $550 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
261 | $56 | $234 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 261 | $134 | $603 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
260 | $49 | $208 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
254 | $1 | $4 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
218 | $1 | $2 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
199 | $73 | $210 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
193 | $22 | $164 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
184 | $6 | $126 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
181 | $25 | $135 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
157 | $61 | $277 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
131 | $3 | $13 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
112 | $51 | $205 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
86 | $2 | $9 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
82 | $19 | $83 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
76 | $45 | $180 |
| New patient office visit, complex (60-74 min) | 73 | $154 | $673 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
71 | $1 | $21 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
61 | $92 | $308 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
51 | $15 | $65 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
48 | $26 | $105 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
43 | $10 | $40 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
37 | $10 | $39 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
33 | $1 | $6 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
28 | $1 | $6 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
27 | $30 | $121 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
27 | $117 | $509 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
24 | $130 | $595 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
21 | $4 | $12 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
21 | $77 | $313 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
20 | $3 | $11 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
41.4% high complexity
51.5% medium
7.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,339
Total received (2018-2024)
Avg $2,191/year across 7 years
Top 29% in WA for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
88
Companies
573
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,395
2023
$2,856
2022
$3,095
2021
$2,379
2020
$725
2019
$1,779
2018
$1,111
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$819
ABBVIE INC.
$326
AstraZeneca Pharmaceuticals LP
$249
Janssen Biotech, Inc.
$205
Stemline Therapeutics Inc.
$161
Celgene Corporation
$143
Merck Sharp & Dohme LLC
$135
PFIZER INC.
$127
Tempus AI, Inc
$74
BeiGene USA, Inc.
$74
Bayer Healthcare Pharmaceuticals Inc.
$69
Takeda Pharmaceuticals U.S.A., Inc.
$65
Ipsen Biopharmaceuticals, Inc
$63
Lilly USA, LLC
$63
GlaxoSmithKline, LLC.
$63
ARRAY BIOPHARMA INC
$61
Regeneron Healthcare Solutions, Inc.
$55
E.R. Squibb & Sons, L.L.C.
$49
SOBI, INC
$43
Boehringer Ingelheim Pharmaceuticals, Inc.
$41
Daiichi Sankyo Inc.
$41
Incyte Corporation
$39
GENZYME CORPORATION
$39
SpringWorks Therapeutics, Inc.
$38
Astellas Pharma US Inc
$36
Eisai Inc.
$36
Pharmacosmos Therapeutics Inc.
$32
PROGENICS PHARMACEUTICALS, INC.
$29
Dendreon Pharmaceuticals LLC
$29
Acrotech Biopharma Inc.
$28
Genentech USA, Inc.
$23
Myriad Genetic Laboratories, Inc.
$23
SERVIER PHARMACEUTICALS LLC
$22
Spectrum Pharmaceuticals Inc.
$21
Mirati Therapeutics, Inc.
$21
PUMA BIOTECHNOLOGY, INC.
$19
ADC Therapeutics America, Inc.
$18
Agios Pharmaceuticals, Inc.
$18
Top 3 companies account for 41.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,967
AstraZeneca Pharmaceuticals LP
$1,127
Seagen Inc.
$1,053
E.R. Squibb & Sons, L.L.C.
$860
Celgene Corporation
$820
Genentech USA, Inc.
$711
Janssen Biotech, Inc.
$684
Amgen Inc.
$522
Incyte Corporation
$453
Astellas Pharma US Inc
$422
Merck Sharp & Dohme LLC
$372
Exelixis Inc.
$367
Pharmacyclics LLC, An AbbVie Company
$363
Lilly USA, LLC
$336
ABBVIE INC.
$326
PFIZER INC.
$302
GENZYME CORPORATION
$267
ARRAY BIOPHARMA INC
$169
NOVARTIS PHARMACEUTICALS CORPORATION
$167
Bayer HealthCare Pharmaceuticals Inc.
$165
Ipsen Biopharmaceuticals, Inc
$163
Stemline Therapeutics Inc.
$161
Boehringer Ingelheim Pharmaceuticals, Inc.
$145
Seattle Genetics, Inc.
$140
Rigel Pharmaceuticals, Inc.
$130
Epizyme, Inc.,
$126
GlaxoSmithKline, LLC.
$125
Aurobindo Pharma USA, Inc.
$124
Merck Sharp & Dohme Corporation
$116
Pharmacyclics LLC, an AbbVie Company
$115
Daiichi Sankyo Inc.
$115
BeiGene USA, Inc.
$112
Bayer Healthcare Pharmaceuticals Inc.
$110
Eisai Inc.
$100
Clovis Oncology, Inc.
$98
Takeda Pharmaceuticals U.S.A., Inc.
$96
EISAI INC.
$88
Janssen Scientific Affairs, LLC
$78
TESARO, Inc.
$77
Tempus AI, Inc
$74
ASD SPECIALTY HEALTHCARE, LLC
$69
AbbVie Inc.
$68
MorphoSys, US Inc.
$65
GE HealthCare
$64
AbbVie, Inc.
$58
Agios Pharmaceuticals, Inc.
$57
Taiho Oncology, Inc.
$56
Regeneron Healthcare Solutions, Inc.
$55
JAZZ PHARMACEUTICALS INC.
$53
Myriad Genetic Laboratories, Inc.
$53
TerSera Therapeutics LLC
$49
CTI BioPharma Corp.
$48
Kite Pharma, Inc.
$46
SOBI, INC
$43
PUMA BIOTECHNOLOGY, INC.
$41
Apellis Pharmaceuticals, Inc.
$40
SpringWorks Therapeutics, Inc.
$38
TG Therapeutics, Inc.
$36
Genmab U.S., Inc.
$35
Deciphera Pharmaceuticals Inc.
$32
Pharmacosmos Therapeutics Inc.
$32
Gilead Sciences, Inc.
$31
Coherus Biosciences Inc.
$30
PROGENICS PHARMACEUTICALS, INC.
$29
Dendreon Pharmaceuticals LLC
$29
Acrotech Biopharma Inc.
$28
Mylan Institutional Inc.
$22
SERVIER PHARMACEUTICALS LLC
$22
GE HEALTHCARE
$22
Spectrum Pharmaceuticals Inc.
$21
Mirati Therapeutics, Inc.
$21
RECORDATI_RARE_DISEASES_INC.
$20
TG THERAPEUTICS, INC.
$20
Octapharma USA, Inc.
$20
Puma Biotechnology, Inc.
$20
Alnylam Pharmaceuticals Inc.
$20
Dova Pharmaceuticals
$19
Secura Bio, Inc.
$19
Horizon Pharma plc
$18
ADC Therapeutics America, Inc.
$18
Blueprint Medicines Corporation
$18
Horizon Therapeutics plc
$18
Alexion Pharmaceuticals, Inc.
$17
Sun Pharmaceutical Industries Inc.
$17
Myovant Sciences Inc.
$17
Karyopharm Therapeutics Inc.
$16
Adaptive Biotechnologies Corporation
$15
Advanced Accelerator Applications
$13
Top 3 companies account for 27.0% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · AYVAKIT · Abraxane · Alecensa · Avastin · BELEODAQ · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · CHANTIX · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELREXFIO · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Empaveli · Enhertu · Epkinly · Erleada · FASLODEX · FRUZAQLA · Farydak · Folotyn · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · Itovebi · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · NERLYNX · NINLARO · Nplate · Nubeqa · OCTAGAM · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXLUMO · Ogivri · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PROMACTA · PROVENGE · PYLARIFY · PYRUKYND · Padcev · Perjeta · Polivy · Pomalyst · QINLOCK · QUZYTTIR · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · SYLVANT · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TEVIMBRA · TIVDAK · TUKYSA · Tavalisse · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · Venclexta · Vitrakvi · Vonjo · Vyloy · WELIREG · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Xospata · YONSA · ZEJULA · ZEPZELCA · ZYTIGA · Zoladex · clonoSEQ · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
5
County median income
$93,985
Nearest hospital to ZIP centroid (approximate)
CAPITAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | — Not enrolled | N/A |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Xuan is a mixed practice specialist, with above-average Medicare volume (top 4% in WA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Xuan experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Xuan performed 36,720 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Xuan receive payments from pharmaceutical companies?
Yes. Dr. Xuan received a total of $15,339 from 88 companies across 573 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Xuan's costs compare to other medical oncologists in Olympia?
Dr. Xuan's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Xuan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Olympia
Browse medical oncologists in Olympia ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in WA
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in WA
Which WA medical oncologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Seagen Inc. Payments to Doctors
See all physicians who received payments from Seagen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology